Cathie Wood Fate Therapeutics Inc Transaction History

Ark Investment Management LLC

$10.5 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 24, 2023	SELL	$9.86 - $23.83 $73.4 Million - $177 Million	-7,440,970 Reduced 63.84%	4,214,863 $0
Q3 2022 Oct 17, 2022	BUY	$21.04 - $36.06 $3.83 Million - $6.57 Million	182,178 Added 1.59%	11,655,833 $261 Million
Q2 2022 Jul 11, 2022	BUY	$17.78 - $42.39 $8.63 Million - $20.6 Million	485,473 Added 4.42%	11,473,655 $265 Million
Q1 2022 Apr 19, 2022	BUY	$29.67 - $60.28 $20.1 Million - $40.8 Million	676,015 Added 6.56%	10,988,182 $426 Million
Q4 2021 Jan 28, 2022	SELL	$47.84 - $64.34 $28.2 Million - $38 Million	-590,091 Reduced 5.41%	10,312,167 $603 Million
Q3 2021 Nov 12, 2021	BUY	$59.27 - $95.73 $203 Million - $327 Million	3,419,156 Added 45.69%	10,902,258 $646 Million
Q2 2021 Aug 05, 2021	BUY	$67.25 - $92.52 $62.4 Million - $85.9 Million	928,556 Added 14.17%	7,483,102 $649 Million
Q1 2021 May 13, 2021	BUY	$72.16 - $117.4 $264 Million - $429 Million	3,652,846 Added 125.89%	6,554,546 $540 Million
Q4 2020 Feb 12, 2021	BUY	$38.09 - $100.95 $55.7 Million - $148 Million	1,461,730 Added 101.51%	2,901,700 $264 Million
Q3 2020 Oct 30, 2020	BUY	$30.41 - $40.5 $12.8 Million - $17 Million	420,140 Added 41.2%	1,439,970 $57.6 Million
Q2 2020 Aug 11, 2020	BUY	$20.21 - $35.23 $9.39 Million - $16.4 Million	464,748 Added 83.73%	1,019,830 $35 Million
Q1 2020 May 14, 2020	BUY	$17.28 - $31.88 $2.14 Million - $3.95 Million	123,954 Added 28.75%	555,082 $12.3 Million
Q4 2019 Jan 31, 2020	BUY	$13.39 - $20.73 $1.23 Million - $1.91 Million	92,089 Added 27.16%	431,128 $8.44 Million
Q3 2019 Nov 12, 2019	BUY	$15.47 - $22.5 $1.81 Million - $2.63 Million	116,975 Added 52.68%	339,039 $5.27 Million
Q2 2019 Jul 30, 2019	BUY	$15.61 - $20.44 $3.47 Million - $4.54 Million	222,064 New	222,064 $4.51 Million

Others Institutions Holding FATE

# of Institutions

175

Shares Held

115M

Call Options Held

53.7K

Put Options Held

Redmile Group, LLC San Francisco, CA

13.2M
Shares

$29.2 Million
3.01% of portfolio
Vanguard Group Inc Valley Forge, PA

10.4M
Shares

$23.1 Million
0.0% of portfolio
Black Rock Inc. New York, NY

10.1M
Shares

$22.5 Million
0.0% of portfolio
Deep Track Capital, LP Greenwich, CT

5.57M
Shares

$12.4 Million
0.72% of portfolio
State Street Corp Boston, MA

5.25M
Shares

$11.7 Million
0.0% of portfolio

View Full List

About FATE THERAPEUTICS INC

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $215M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

More about FATE

Track Cathie Wood's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ark Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ark Investment Management LLC and Cathie Wood with notifications on news.

Account